Evidence map›Paper›PMID 42232237›Full record

ArticleeGastroenterology2026

TERT rs10069690 variant is linked to reduced cholangiocarcinoma incidence but adverse prognosis in patients undergoing resection.

Isabella Lurje, Justus Pein, Paul Horn, Deniz Uluk, Marlene Kohlhepp, Minh Duc Phan, Saskia Niklisch, Frederik Schliephake, Niharika Jakhar, Kai Markus Schneider and 6 more

Abstract read
In one paragraph

Article in eGastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Isabella LurjeDepartment of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-4006-7707
Justus PeinDepartment of Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Paul HornDepartment of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-8755-7703
Deniz UlukDepartment of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Marlene KohlheppDepartment of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Minh Duc PhanDepartment of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Saskia NiklischDepartment of Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Frederik SchliephakeDepartment of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Niharika JakharDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Kai Markus SchneiderDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Florian RoßnerInstitute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
David HorstInstitute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Johann PratschkeDepartment of Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Frank TackeDepartment of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0001-6206-0226
Carolin Victoria SchneiderDepartment of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.ORCID https://orcid.org/0000-0002-6728-9246
Georg LurjeDepartment of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cholangiocarcinoma (CCA) is a rare cancer, with limited understanding of genetic and prognostic determinants. We aimed to explore genetic risk factors, assess their prognostic implications and evaluate associated systemic and intratumoral features. Methods: We screened the UK Biobank to identify single-nucleotide polymorphisms (SNPs) potentially associated with intrahepatic CCA (International Classification of Diseases, 10th Revision (ICD-10) code: C22.1). Candidate SNPs were genotyped in a real-life cohort of 221 patients undergoing liver resection for intrahepatic or perihilar CCA at Charité - Universitätsmedizin Berlin. Intratumoral gene expression and pathway co-expression were examined. Serum proteomic profiles were evaluated in patients with intrahepatic CCA and the overall population. Results: In exploratory analyses, the telomerase reverse transcriptase Conclusions: These exploratory, hypothesis-generating findings suggest that the

Indexed as

CholangiocarcinomaPolymorphism, Single NucleotidePrognosisProteomicsTelomerase

Identifiers

PMID42232237
PMCPMC13223632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.